
Microport Cardioflow Medtech Corp
HKEX:2160

Microport Cardioflow Medtech Corp
Revenue
Microport Cardioflow Medtech Corp
Revenue Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
Company | Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
---|---|---|---|---|---|---|
![]() |
Microport Cardioflow Medtech Corp
HKEX:2160
|
Revenue
ÂĄ361.6m
|
CAGR 3-Years
22%
|
CAGR 5-Years
76%
|
CAGR 10-Years
N/A
|
|
A
|
APT Medical Inc
SSE:688617
|
Revenue
ÂĄ1.7B
|
CAGR 3-Years
51%
|
CAGR 5-Years
47%
|
CAGR 10-Years
N/A
|
|
J
|
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SZSE:002223
|
Revenue
ÂĄ7.3B
|
CAGR 3-Years
1%
|
CAGR 5-Years
10%
|
CAGR 10-Years
16%
|
|
![]() |
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
|
Revenue
ÂĄ37.1B
|
CAGR 3-Years
15%
|
CAGR 5-Years
19%
|
CAGR 10-Years
N/A
|
|
L
|
Lepu Medical Technology Beijing Co Ltd
SZSE:300003
|
Revenue
ÂĄ6.5B
|
CAGR 3-Years
-14%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
15%
|
|
![]() |
Shanghai United Imaging Healthcare Co Ltd
SSE:688271
|
Revenue
ÂĄ11.4B
|
CAGR 3-Years
26%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
Microport Cardioflow Medtech Corp
Glance View
MicroPort CardioFlow Medtech Corp. operates as a holding company with interest in developing medical devices. The company is headquartered in Shanghai, Shanghai. The company went IPO on 2021-02-04. The firm is mainly engaged in the development and commercialization of transcatheter and surgical solutions for valvular heart diseases. The firm's main products include the first-generation transcatheter aortic heart valve implantation (TAVI) product VitaFlow and the second-generation TAVI product VitaFlow II. The firm mainly conducts business within the domestic market.

See Also
What is Microport Cardioflow Medtech Corp's Revenue?
Revenue
361.6m
CNY
Based on the financial report for Dec 31, 2024, Microport Cardioflow Medtech Corp's Revenue amounts to 361.6m CNY.
What is Microport Cardioflow Medtech Corp's Revenue growth rate?
Revenue CAGR 5Y
76%
Over the last year, the Revenue growth was 8%. The average annual Revenue growth rates for Microport Cardioflow Medtech Corp have been 22% over the past three years , 76% over the past five years .